AZITRA INC (AZTR) Stock Price, Quote, News and Overview
NYSEARCA:AZTR - NYSE Arca - US05479L2034 - Common Stock - Currency: USD
AZTR Quote, Performance and Key Statistics
NYSEARCA:AZTR (5/14/2025, 3:08:11 PM)
0.27
-0.01 (-3.57%)
The current stock price of AZTR is 0.27 USD. In the past month the price decreased by -4.11%. In the past year, price decreased by -94.87%.
AZTR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.32 | 314.60B | ||
| AMGN | AMGEN INC | 12.64 | 141.13B | ||
| GILD | GILEAD SCIENCES INC | 12.72 | 122.57B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 108.47B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.91 | 61.76B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.54B | ||
| ARGX | ARGENX SE - ADR | 90.78 | 32.54B | ||
| ONC | BEIGENE LTD-ADR | 5.46 | 23.72B | ||
| BNTX | BIONTECH SE-ADR | N/A | 22.21B | ||
| NTRA | NATERA INC | N/A | 20.55B | ||
| BIIB | BIOGEN INC | 7.61 | 17.63B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.98B |
Related stock screener links
About AZTR
Company Profile
Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The company is headquartered in Branford, Connecticut and currently employs 12 full-time employees. The company went IPO on 2023-06-16. The firm is focused on developing advanced therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. The company has built a proprietary platform that includes a microbial library comprised of approximately 1,500 unique bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its lead product, ATR-12, is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its advanced product, ATR-04, is a genetically modified strain of S. epidermidis for treating papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease.
Company Info
AZITRA INC
21 Business Park Drive, Suite 6
Branford CONNECTICUT US
Employees: 12
Phone: 12034890183
AZITRA INC / AZTR FAQ
What is the stock price of AZITRA INC today?
The current stock price of AZTR is 0.27 USD. The price decreased by -3.57% in the last trading session.
What is the ticker symbol for AZITRA INC stock?
The exchange symbol of AZITRA INC is AZTR and it is listed on the NYSE Arca exchange.
On which exchange is AZTR stock listed?
AZTR stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for AZITRA INC stock?
7 analysts have analysed AZTR and the average price target is 2.55 USD. This implies a price increase of 844.44% is expected in the next year compared to the current price of 0.27. Check the AZITRA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AZITRA INC worth?
AZITRA INC (AZTR) has a market capitalization of 4.04M USD. This makes AZTR a Nano Cap stock.
How many employees does AZITRA INC have?
AZITRA INC (AZTR) currently has 12 employees.
What are the support and resistance levels for AZITRA INC (AZTR) stock?
AZITRA INC (AZTR) has a support level at 0.28 and a resistance level at 0.28. Check the full technical report for a detailed analysis of AZTR support and resistance levels.
Is AZITRA INC (AZTR) expected to grow?
The Revenue of AZITRA INC (AZTR) is expected to decline by -100% in the next year. Check the estimates tab for more information on the AZTR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AZITRA INC (AZTR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AZTR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AZTR, evaluating the profitability, health, valuation and growth aspects
- AZITRA INC (AZTR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AZITRA INC (AZTR) Sales and EPS estimates to see what analysts future expectations are.
- AZITRA INC (AZTR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AZITRA INC (AZTR) Insider and Institutional Ownership to learn about the owners and their transactions.
- AZITRA INC (AZTR) Stock Chart to make your own analysis
- AZITRA INC (AZTR) Latest news and press-releases to stay up to date.
Does AZITRA INC (AZTR) stock pay dividends?
AZTR does not pay a dividend.
What is the Price/Earnings (PE) ratio of AZITRA INC (AZTR)?
AZITRA INC (AZTR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.59).
What is the Short Interest ratio of AZITRA INC (AZTR) stock?
The outstanding short interest for AZITRA INC (AZTR) is 22.07% of its float. Check the ownership tab for more information on the AZTR short interest.
AZTR Technical Analysis
AZTR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AZTR. Both the profitability and financial health of AZTR have multiple concerns.
AZTR Financial Highlights
Over the last trailing twelve months AZTR reported a non-GAAP Earnings per Share(EPS) of -7.59. The EPS decreased by -155.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -121.86% | ||
| ROE | -157.37% | ||
| Debt/Equity | 0 |
AZTR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to AZTR. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 64.39% and a revenue growth -100% for AZTR